Jacky P. Jacquot

Reims, 51097, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.

Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 13, 2020

CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth.

CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 17, 2019

Overexpression of RANK and M-CSFR in Monocytes of G551D-Bearing Patients with Cystic Fibrosis.

Overexpression of RANK and M-CSFR in Monocytes of G551D-Bearing Patients with Cystic Fibrosis.

Journal: American journal of respiratory and critical care medicine
Published: June 26, 2018

An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes.

An Optimized Method to Generate Human Active Osteoclasts From Peripheral Blood Monocytes.

Journal: Frontiers in immunology
Published: December 19, 2017

Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation.

Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 10, 2016

Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis.

Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis.

Journal: The Journal of pathology
Published: April 07, 2016

Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: September 01, 2015

Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

Journal: The European respiratory journal
Published: November 29, 2014

Probing the plasma near high power wave launchers in fusion devices for static and dynamic electric fields (invited).

Probing the plasma near high power wave launchers in fusion devices for static and dynamic electric fields (invited).

Journal: The Review of scientific instruments
Published: November 29, 2014

Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.

Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in cystic fibrosis transmembrane conductance regulator.

Journal: American journal of respiratory and critical care medicine
Published: March 18, 2014

Bone health in cystic fibrosis: use of oral bisphosphonates.

Bone health in cystic fibrosis: use of oral bisphosphonates.

Journal: The Lancet. Respiratory medicine
Published: January 17, 2014

Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.

Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.

Journal: The American journal of pathology
Published: October 28, 2013
Showing 1-12 of 15

Last Updated: 09/26/2026